Reading the tape
NASDAQ: ME
23andMe Holding Co.
Healthcare · Medical - Diagnostics & Research
Market Cap
$15.31M
52w High
$12.76
52w Low
$0.48
P/E
-0.09
Volume
29.75M
Outstanding Shares
25.25M
Not enough data to analyse price vs. fundamentals for this ticker.
Company profile
23andMe Holding Co. operates as a consumer genetics testing company.
CEOJoseph Selsavage
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees560
IPO dateNov 23, 2020
Valuation
Forward P/E—
EV/EBITDA-0.32
Enterprise value$49.27M
Stock splits
Oct 16, 2024↓ Reverse
Every 20 shares became 1
Profitability & growth
Revenue growth-37.1%
Gross margin54.17%▲16.39%vs FY2024
Operating margin-105.65%▲13.39%vs FY2024
ROE1,050.35%▲397.00%vs FY2024
Analyst consensus
RatingBuy
Target price$3.71▲511.91%
3
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2025
Q4 FY25 · EPS est — · Revenue est —
View